Chordate Medical Holding AB (FRA:K1Z) Total Assets : €1.62 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Total Assets?

Chordate Medical Holding AB's Total Assets for the quarter that ended in Sep. 2024 was €1.62 Mil.

During the past 12 months, Chordate Medical Holding AB's average Total Assets Growth Rate was 8.50% per year. During the past 3 years, the average Total Assets Growth Rate was -4.90% per year. During the past 5 years, the average Total Assets Growth Rate was -6.10% per year.

During the past 9 years, Chordate Medical Holding AB's highest 3-Year average Total Assets Growth Rate was -0.70%. The lowest was -24.70%. And the median was -14.00%.

Total Assets is connected with ROA %. Chordate Medical Holding AB's annualized ROA % for the quarter that ended in Sep. 2024 was -100.60%. Total Assets is also linked to Revenue through Asset Turnover. Chordate Medical Holding AB's Asset Turnover for the quarter that ended in Sep. 2024 was 0.01.

Chordate Medical Holding AB Total Assets Historical Data

The historical data trend for Chordate Medical Holding AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Total Assets Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

1.80

3.07

4.29

1.70

1.96

Chordate Medical Holding AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															2.47	1.96	3.05	2.36	1.62

Chordate Medical Holding AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Chordate Medical Holding AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	1.349	+	0.614
	=	1.96

Chordate Medical Holding AB's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	1.321	+	0.294
	=	1.62

Chordate Medical Holding AB (FRA:K1Z) Total Assets Explanation

Total Assets is connected with ROA %.

Chordate Medical Holding AB's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	-2	/	( (2.361	+	1.615)	/ 2 )
	=	-2	/	1.988
	=	-100.60 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Chordate Medical Holding AB's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	0.013	/	( (2.361	+	1.615)	/ 2 )
=	0.013	/	1.988
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Chordate Medical Holding AB Total Assets Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (FRA:K1Z) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

CMH:Sweden

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB Headlines

No Headlines